Tilray Brands (NASDAQ:TLRY – Get Free Report) and Vireo Growth (OTCMKTS:VREOD – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Tilray Brands and Vireo Growth, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tilray Brands | 2 | 2 | 3 | 1 | 2.38 |
| Vireo Growth | 1 | 0 | 0 | 0 | 1.00 |
Tilray Brands presently has a consensus price target of $5.90, indicating a potential upside of 133.20%. Given Tilray Brands’ stronger consensus rating and higher probable upside, equities analysts plainly believe Tilray Brands is more favorable than Vireo Growth.
Valuation & Earnings
This table compares Tilray Brands and Vireo Growth”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tilray Brands | $915.45 million | 0.41 | -$121.40 million | ($1.40) | -1.81 |
| Vireo Growth | $268.77 million | 1.68 | -$68.11 million | ($3.30) | -3.02 |
Vireo Growth has lower revenue, but higher earnings than Tilray Brands. Vireo Growth is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Tilray Brands and Vireo Growth’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tilray Brands | -16.91% | -10.39% | -7.38% |
| Vireo Growth | -23.37% | -19.76% | -7.15% |
Insider and Institutional Ownership
9.3% of Tilray Brands shares are owned by institutional investors. 1.6% of Tilray Brands shares are owned by company insiders. Comparatively, 3.8% of Vireo Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Risk and Volatility
Tilray Brands has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500. Comparatively, Vireo Growth has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500.
Summary
Tilray Brands beats Vireo Growth on 11 of the 15 factors compared between the two stocks.
About Tilray Brands
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
About Vireo Growth
Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
